Strategy Analytics: TWS Earbuds Will Capture 70% of Global Bluetooth Stereo Headset Sales in 2021

BOSTON--(BUSINESS WIRE)-- According to the latest research from Strategy Analytics, global Truly Wireless (TWS) earbuds are out-competing traditional Bluetooth headsets by rapidly adding advanced capabilities found previously only in premium headsets. In 2021 TWS earbuds will account for seven in ten of all Bluetooth headsets sold.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210520005736/en/

Exhibit 1: Global Bluetooth TWS Earbuds Sales Penetration by Technology (Source: Strategy Analytics)

Ville-Petteri Ukonaho, Associate Director at Strategy Analytics, said, “TWS Bluetooth earbuds have become more capable than ever. Consumers are replacing bulky old-style Bluetooth headsets with smaller lighter and often less-expensive TWS earbuds that pack advanced features such as active noise cancellation, heart-rate monitoring, water resistance and wireless charging.”

“TWS earbuds now often have features not found in traditional banded Bluetooth headsets,” says Ken Hyers, Director at Strategy Analytics. “TWS earbuds better fit modern consumers lifestyles. While Apple’s AirPods are the most popular brand, vendors from around the world, ranging from Bose in the USA to Xiaomi in China and Boat in India are all introducing new TWS earbuds with advance features that capture consumers’ notice.”

“Powering these advanced features are tech vendors like Qualcomm, whose Clear Voice Capture technology is the key to providing noise cancelling to improve sound quality in many TWS earbuds,” says Ville-Petteri Ukonaho, Associate Director at Strategy Analytics. “Other system-on-chip (soC) solutions providers include Realtek, AppoTech, Actions, BES and Cypress. Prices for these technologies are continuing to fall. In 2021 52% of all TWS earbuds with noise cancellation will have a wholesale price of $50 or less, making them more affordable for more consumers.”

“TWS earbuds are adding other technologies for consumers engaging in active lifestyles,” says Mr. Ukonaho. “Over 30% of TWS earbuds sold in 2021 will be water resistant, meaning consumers engaging in high-impact activities like exercise will be able to enjoy music, podcasts and phone calls without having to worry that their TWS earbuds will be damaged by sweat or an unanticipated rain shower. Heart rate monitors are in 4% of TWS earbuds that will be sold in 2021, allowing users to track a key health metric. And transparency features allow users to hear surrounding sounds when being fully absorbed in music isn’t ideal. This is an important safety feature for joggers and bicyclists who need to be able to hear real-world sounds.”

About Strategy Analytics

Strategy Analytics, Inc. is a global leader in supporting companies across their planning lifecycle through a range of customized market research solutions. Our multi-discipline capabilities include: industry research advisory services, customer insights, user experience design and innovation expertise, mobile consumer on-device tracking and business-to-business consulting competencies. With domain expertise in: smart devices, connected cars, intelligent home, service providers, IoT, strategic components and media, Strategy Analytics can develop a solution to meet your specific planning need. For more information, visit us at www.strategyanalytics.com.

Source: Strategy Analytics, Inc.

#SA_Devices

For more information about Strategy Analytics

Service Name: Bluetooth Device Tracker

View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005736/en/

Report contacts:
Europe: Ville-Petteri Ukonaho, +44 (0)1908 423 634, [email protected]
Americas: Ken Hyers, +1 617 614 0757, [email protected]
Asia: Woody Oh, +44 (0)1908 423 665, [email protected]

Source: Strategy Analytics

You May Also Be Interested In

• AGM Trading Update - April 2024
• AS Tallink Grupp Unaudited Consolidated Interim Report Q1 2024
• ACTICOR BIOTECH: Topline Results of ACTISAVE Phase 2/3 Study in Stroke Treatment